neratinib
Drug timelines are a Plus or Pro feature.
51 regulatory and trial events tracked for neratinib, covering 2012-05-14 to 2026-04-24. Get the full timeline:
Most recent: Clinical Trial Update: Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial) [Phase 2]